{
    "eid": "2-s2.0-85148580907",
    "title": "Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Dhakrit Rungkitwattanakul",
        "Taniya Charoensareerat",
        "Ekanong Chaichoke",
        "Thanakorn Rakamthong",
        "Pitchaya Srisang",
        "Sutthiporn Pattharachayakul",
        "Nattachai Srisawat",
        "Weerachai Chaijamorn"
    ],
    "citedby-count": 0,
    "ref-count": 42,
    "ref-list": [
        "Continuous renal replacement therapy in critically ill patients",
        "Acute kidney injury, acute lung injury and septic shock: how does mortality compare?",
        "Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients",
        "Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses",
        "Population pharmacokinetics and dosing optimization of piperacillin-tazobactam in critically ill patients on extracorporeal membrane oxygenation and the influence of concomitant renal replacement therapy",
        "Optimizing \u03b2-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?",
        "Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists",
        "Population pharmacokinetics/pharmacodynamics and clinical outcomes of Meropenem in critically ill patients",
        "The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome",
        "Recommended \u03b2-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy",
        "The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study",
        "Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study",
        "Optimal levofloxacin dosing regimens in critically ill patients with acute kidney injury receiving continuous renal replacement therapy",
        "Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis",
        "Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration",
        "Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT",
        "Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration",
        "Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure",
        "Pharmacokinetics and pharmacodynamics of extended infusion versus short infusion piperacillin-tazobactam in critically ill patients undergoing CRRT",
        "Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration",
        "First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis",
        "KDIGO clinical practice guidelines for acute kidney injury",
        "Management of renal replacement therapy in ICU patients: an international survey",
        "Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy",
        "Neurotoxic concentration of piperacillin during continuous infusion in critically ill patients",
        "Clinical review: drug metabolism and nonrenal clearance in acute kidney injury",
        "Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration",
        "We underdose antibiotics in patients on CRRT",
        "Antibiotic dosing in patients with acute kidney injury: \u201cenough but not too much\u201d",
        "Nonlinear pharmacokinetics of piperacillin in healthy volunteers\u2014implications for optimal dosage regimens: population pharmacokinetics and pharmacodynamics of piperacillin",
        "State-of-the-art clinical article: pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men",
        "Optimization of the treatment with beta-lactam antibiotics in critically ill patients\u2014guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique\u2014SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et R\u00e9animation\u2014SFAR)",
        "Pharmacokinetics of piperacillin and tazobactam in critically ill patients treated with continuous kidney replacement therapy: a mini-review and population pharmacokinetic analysis",
        "Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections",
        "Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections",
        "Pharmacodynamics of cefepime in patients with gram-negative infections",
        "Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?",
        "Ex vivo ceftolozane/tazobactam clearance during continuous renal replacement therapy",
        "Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia",
        "Piperacillin penetration into tissue of critically ill patients with sepsis\u2014bolus versus continuous administration?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Washington, D.C.",
            "@id": "60012771",
            "affilname": "Howard University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012771",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Siam University"
    ]
}